Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Livzon Pharmaceutical Group ( (HK:1513) ) has issued an announcement.
Livzon Pharmaceutical Group has approved a new series of continuing connected transactions with its controlling shareholder Joincare for the 2026 financial year, covering the supply of utilities, mutual provision of labour services, and the sale and purchase of products between the two groups. The parties have signed five framework agreements effective from 1 January to 31 December 2026, with annual caps of RMB36 million for water, electricity, steam, natural gas and sewage treatment, RMB33 million and RMB170 million for the receipt and provision of labour services, and RMB38 million and RMB310 million for product sales and purchases respectively. As the percentage ratios for these transactions fall between 0.1% and 5% under Hong Kong Listing Rules, they are classified as continuing connected transactions requiring public reporting and announcement but are exempt from independent shareholders’ approval, underscoring Livzon’s ongoing operational reliance on related-party arrangements while remaining within regulatory thresholds for such dealings.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$37.23 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group is a Hong Kong–listed pharmaceutical company whose controlling shareholder, Joincare Pharmaceutical Group, holds about 46.33% of its equity. Operating within the healthcare and pharmaceuticals sector, Livzon both manufactures and sells pharmaceutical products and also engages in intra-group procurement, utilities and labour-services arrangements with Joincare to support its production and operations.
Average Trading Volume: 735,449
Technical Sentiment Signal: Hold
Current Market Cap: HK$32.19B
See more insights into 1513 stock on TipRanks’ Stock Analysis page.